ArticleClinical cancer research : an official journal of the American Association for Cancer Research2021

BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program.

Dae-Hwan Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.